CoChat

Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients

Open access
Cucchiari, David, Egri, Natalia, Bodro, Marta, Herrera, Sabina, Del Risco-Zevallos, Jimena, Casals-Urquiza, Joaquim, Cofan, Frederic, Moreno, Asunción, Rovira, Jordi, Banon-Maneus, Elisenda, Ramirez-Bajo, Maria J., Ventura-Aguiar, Pedro, Pérez-Olmos, Anna, Garcia-Pascual, Marta, Pascal, Mariona, Vilella, Anna, Trilla, Antoni, Ríos, José, Palou, Eduard, Juan, Manel, Bayés, Beatriu, Diekmann, Fritz · 2021 · American Journal of Transplantation
Cited by 231

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

According to preliminary data, seroconversion after mRNA SARS-CoV-2 vaccination might be unsatisfactory in Kidney Transplant Recipients (KTRs). However, it is unknown if seronegative patients develop at least a cellular response that could offer a certain grade of protection against SARS-CoV-2. To answer this question, we prospectively studied 148 recipients of either kidney (133) or kidney-pancreas (15) grafts with assessment of IgM/IgG spike (S) antibodies and ELISpot against the nucleocapside (N) and the S protein at baseline and 2 weeks after receiving the second dose of the mRNA-1273 (Moderna) vaccine. At baseline, 31 patients (20.9%) had either IgM/IgG or ELISpot positivity and were considered to be SARS-CoV-2-pre-immunized, while 117 (79.1%) patients had no signs of either cellular or humoral response and were considered SARS-CoV-2-naïve. After vaccination, naïve patients who developed either humoral or cellular response were finally 65.0%, of which 29.9% developed either IgG or IgM and 35.0% S-ELISpot positivity. Factors associated with vaccine unresponsiveness were diabetes and treatment with antithymocytes globulins during the last year. Side effects were consistent with that of the pivotal trial and no DSAs developed after vaccination. In conclusion, mRNA-1273 SARS-CoV-2 vaccine elicits either cellular or humoral response in almost two thirds of KTRs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ajt.16701

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 231

Metadata

Authors
Cucchiari, D., Egri, N., Bodro, M., Herrera, S., Del Risco-Zevallos, J., Casals-Urquiza, J., Cofan, F., Moreno, A., Rovira, J., Banon-Maneus, E., Ramirez-Bajo, M. J., Ventura-Aguiar, P., Pérez-Olmos, A., Garcia-Pascual, M., Pascal, M., Vilella, A., Trilla, A., Ríos, J., Palou, E., Juan, M., Bayés, B., & Diekmann, F.
Venue
American Journal of Transplantation
Publisher
Elsevier BV
Published
2021-08
Volume
21
Issue
8
Pages
2727-2739
ISSN
1600-6135 (ISSN-L)
OpenAlex
W3165003372
Cited by
231
References
5
FWCI
16.36
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients. https://app.cochat.ai/papers/10.1111/ajt.16701
The paper
Cucchiari, D., Egri, N., Bodro, M., Herrera, S., Del Risco-Zevallos, J., Casals-Urquiza, J., Cofan, F., Moreno, A., Rovira, J., Banon-Maneus, E., Ramirez-Bajo, M. J., Ventura-Aguiar, P., Pérez-Olmos, A., Garcia-Pascual, M., Pascal, M., Vilella, A., Trilla, A., Ríos, J., Palou, E., . . . Diekmann, F. (2021). Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients. American Journal of Transplantation. https://doi.org/10.1111/ajt.16701

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.